Microbiological Investigations of Fine Needle Aspirates from Newly Suspected and Previously Treated Tubercular Lymphadenitis Patients

References

• Ramírez-Lapausa M, Menéndez-Saldaña A, Noguerado-Asensio A. Tuberculosis extrapulmonar, una revisión[Extrapulmonary tuberculosis]. Rev Esp Sanid Penit. 2015;17(1):3–11. Spanish. doi:10.4321/S1575-06202015000100002
   PubMedGoogle Scholar
• Moule MG, Cirillo JD. Mycobacterium tuberculosis dissemination plays a critical role in pathogenesis. Front Cell Infect Microbiol. 2020;10:65. doi:10.3389/fcimb.2020.00065
   PubMed Web of Science ®Google Scholar
• Chang CC, Sheikh V, Sereti I, French MA. Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment. Curr HIV/AIDS Rep. 2014;11(3):223–232.
   PubMed Web of Science ®Google Scholar
• Cataño JC, Robledo J, Schlossberg D. Tuberculous Lymphadenitis and Parotitis. Microbiol Spectr. 2016;4:6. doi:10.1128/microbiolspec.TNMI7-0008-2016
   Web of Science ®Google Scholar
• Kimura Y, Shimada M, Kawashima M, Yamane A, Nagai H, Matsui H. Relapse of cervical tuberculous lymphadenitis immediately after completion of effective anti-tuberculosis treatments. Respirol Case Rep. 2020;8(4):e00555. doi:10.1002/rcr2.555
   PubMed Web of Science ®Google Scholar
• Rumende CM. Risk factors for multidrug-resistant tuberculosis. Acta medica Indonesiana. 2018;50(1):1–2.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report 2022. World Health Organization; 2022.
   Google Scholar
• Assefa G, Desta K, Araya S, et al. Drug resistance in tuberculous lymphadenitis: molecular characterization. Tuberc Res Treat. 2023;2023:3291538. doi:10.1155/2023/3291538
   PubMedGoogle Scholar
• Dusthackeer A, Sekar G, Chidambaram S, Kumar V, Mehta P, Swaminathan S. Drug resistance among extrapulmonary TB patients: six years experience from a supranational reference laboratory. Indian J Med Res. 2015;142(5):568–574. doi:10.4103/0971-5916.171284
   PubMedGoogle Scholar
• Kirimuhuzya C. Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis? IntechOpen; 2012.
   Google Scholar
• Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41(1):21–43.
   PubMed Web of Science ®Google Scholar
• Palomino JC. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol. 2009;56(2):103–111. doi:10.1111/j.1574-695X.2009.00555.x
   PubMedGoogle Scholar
• Steingart KR, Sohn H, Schiller I, et al.Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2013;(1):CD009593–CD. doi:10.1002/14651858.CD009593.pub2
   PubMed Web of Science ®Google Scholar
• Belay M, Ameni G, Bjune G, Couvin D, Rastogi N, Abebe F. Strain diversity of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Afar pastoral region of Ethiopia. Biomed Res Int. 2014;2014:238532. doi:10.1155/2014/238532
   PubMed Web of Science ®Google Scholar
• Haeili M, Darban-Sarokhalil D, Fooladi AAI, et al. Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran. Microbiol Open. 2013;2(6):988–996. doi:10.1002/mbo3.139
   Google Scholar
• Getachew A, Tesfahunegn Z. Is fine needle aspiration cytology a useful tool for the diagnosis of tuberculous lymphadenitis? East Afr Med J. 1999;76(5):260–263.
   PubMed Web of Science ®Google Scholar
• Nerurkar V, Kattungal S, Bhatia S. Utility of MPT64 antigen test for differentiating mycobacteria: can correlation with liquid culture smear morphology add further value? Indian J Pathol Microbiol. 2016;59(2):185–187. doi:10.4103/0377-4929.182009
   PubMed Web of Science ®Google Scholar
• Atnafu A, Desta K, Girma S, et al. Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients. PLoS One. 2022;17(3):e0265499. doi:10.1371/journal.pone.0265499
   PubMed Web of Science ®Google Scholar
• Mittal P, Handa U, Mohan H, Gupta V. Comparative evaluation of fine needle aspiration cytology, culture, and PCR in diagnosis of tuberculous lymphadenitis. Diagn Cytopathol. 2011;39(11):822–826. doi:10.1002/dc.21472
   PubMed Web of Science ®Google Scholar
• Aljafari AS, Khalil EA, Elsiddig KE, et al. Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study. Cytopathology. 2004;15(1):44–48. doi:10.1111/j.1365-2303.2003.00119.x
   PubMed Web of Science ®Google Scholar
• Chand P, Dogra R, Chauhan N, Gupta R, Khare P. Cytopathological pattern of tubercular lymphadenopathy on FNAC: analysis of 550 consecutive cases. J Clin Diagn Res. 2014;8(9):Fc16–Fc19. doi:10.7860/JCDR/2014/9956.4910
   PubMedGoogle Scholar
• Mistry Y, Ninama GL, Mistry K, Rajat R, Parmar R, Godhani A. Efficacy of fine needle aspiration cytology, Ziehl-Neelsen stain and culture (Bactec) in diagnosis of tuberculosis lymphadenitis. Natl J Med Res. 2012;2(01):77–80.
   Google Scholar
• Campbell IA. The treatment of superficial tuberculous lymphadenitis. Tubercle. 1990;71(1):1–3. doi:10.1016/0041-3879(90)90052-A
   PubMedGoogle Scholar
• Park KH, Cho OH, Chong YP, et al. Post-therapy paradoxical response in immunocompetent patients with lymph node tuberculosis. J Infect. 2010;61(5):430–434. doi:10.1016/j.jinf.2010.08.011
   PubMed Web of Science ®Google Scholar
• Cho OH, Park KH, Kim T, et al. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect. 2009;59(1):56–61. doi:10.1016/j.jinf.2009.05.006
   PubMed Web of Science ®Google Scholar
• Hawkey CR, Yap T, Pereira J, et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis. 2005;40(9):1368–1371. doi:10.1086/429317
   PubMed Web of Science ®Google Scholar
• Park KH, Lee MS, Lee SO, et al. Incidence and outcomes of paradoxical lymph node enlargement after anti-tuberculosis therapy in non-HIV patients. J Infect. 2013;67(5):408–415. doi:10.1016/j.jinf.2013.07.022
   PubMed Web of Science ®Google Scholar
• Ayalew S, Wegayehu T, Taye H, et al. Drug resistance conferring mutation and genetic diversity of mycobacterium tuberculosis isolates in tuberculosis lymphadenitis patients; Ethiopia. Infect Drug Resist. 2021;14:575–584. doi:10.2147/IDR.S298683
   PubMed Web of Science ®Google Scholar
• Gashaw F, Erko B, Mekonnen Y, et al. Phenotypic and genotypic drug sensitivity profiles of Mycobacterium tuberculosis infection and associated factors in northeastern Ethiopia. BMC Infect Dis. 2021;21(1):261. doi:10.1186/s12879-021-05961-8
   PubMed Web of Science ®Google Scholar
• Biadglegne F, Mulu A, Rodloff AC, Sack U. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia. Tuberculosis. 2014;94(5):502–505. doi:10.1016/j.tube.2014.05.002
   PubMed Web of Science ®Google Scholar
• Raja R, Sreeramulu PN, Dave P, Srinivasan D. GeneXpert assay - A cutting-edge tool for rapid tissue diagnosis of tuberculous lymphadenitis. J Clin Tuberc Other Bycobact Dis. 2020;21:100204. doi:10.1016/j.jctube.2020.100204
   PubMedGoogle Scholar
• Mukhida S, Vyawahare CR, Mirza SB, et al. Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance. Tzu Chi Med J. 2022;34(4):418–422. doi:10.4103/tcmj.tcmj_86_22
   PubMed Web of Science ®Google Scholar
• Habous M, Elimam MA, Kumar R, Deesi ZA. Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens. Int J Mycobacteriol. 2019;8(2):132–137. doi:10.4103/ijmy.ijmy_83_19
   PubMed Web of Science ®Google Scholar